RT Book, Section
A1 Tarhini, Ahmad A.
A1 Gillespie-Twardy, Amanda L.
A1 Kirkwood, John M.
A2 Boyiadzis, Michael M.
A2 Frame, James N.
A2 Kohler, David R.
A2 Fojo, Tito
SR Print(0)
ID 1128254570
T1 Melanoma
T2 Hematology-Oncology Therapy, 2e
YR 2016
FD 2016
PB McGraw-Hill Education
PP New York, NY
SN 9780071637893
LK hemonc.mhmedical.com/content.aspx?aid=1128254570
RD 2024/04/24
AB EpidemiologyTable  Graphic  Jump  Location|Download  (.pdf)|PrintEpidemiologyIncidence:76,100  (male:  43,890;  female:  32,210.  Estimated  new  cases  for  2014  in  the  United  States)Stage  at  PresentationStage  0:49.3%21.1  per  100,000  male  and  female  per  year  (27.4  per  100,000  male  16.7  per  100,000  female)Stage  I:36.3%Stage  II:7.3%  Deaths:Estimated  9,710  in  2014  (male:  6,470;  female:  3,240)Stage  III:3.7%  Median  age:61  yearsStage  IV:3.4%Male  to  female  ratio:1.5:1Koh  HK.  N  Engl  J  Med  1991;325:171–182National  Cancer  Institute,  Surveillance,  Epidemiology  and  End  Results  (SEER)  ProgramSiegel  R  et  al.  CA  Cancer  J  Clin  2014;64:9–29Surveillance,  Epidemiology  and  End  Results  (SEER)  Program,  available  from  http://seer.cancer.gov  (accessed  in  2013)